Integrated Biopharma Price on February 1, 2023

INBPDelisted Stock  USD 0.33  0.00  0.00%   
If you're considering investing in Integrated OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Integrated Biopharma stands at 0.33, as last reported on the 30th of November, with the highest price reaching 0.33 and the lowest price hitting 0.32 during the day. We have found twenty-two technical indicators for Integrated Biopharma, which you can use to evaluate the volatility of the firm. Please check out Integrated Biopharma's Standard Deviation of 4.05, risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (0.39) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Integrated OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
INBP
Based on monthly moving average Integrated Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Biopharma by adding Integrated Biopharma to a well-diversified portfolio.

Integrated Biopharma Valuation on February 1, 2023

It is possible to determine the worth of Integrated Biopharma on a given historical date. On February 1, 2023 Integrated was worth 0.35 at the beginning of the trading date compared to the closed value of 0.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Integrated Biopharma otc stock. Still, in general, we apply an absolute valuation method to find Integrated Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integrated Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Integrated Biopharma's related companies.
 Open High Low Close Volume
  0.35    0.35    0.35    0.35    10,150  
02/01/2023
  0.35    0.35    0.35    0.35    1.00  
  0.35    0.35    0.35    0.35    1.00  
Backtest Integrated Biopharma  |  Integrated Biopharma History  |  Integrated Biopharma Valuation   PreviousNext  
Open Value
0.35
0.35
Closing Value
0.35
Upside

Integrated Biopharma Trading Date Momentum on February 1, 2023

On February 02 2023 Integrated Biopharma was traded for  0.35  at the closing time. The top price for the day was 0.35  and the lowest listed price was  0.35 . There was no trading activity during the period 1.0. Lack of trading volume on February 2, 2023 did not cause price change. The trading delta at closing time against the current closing price is 0.00% .

Integrated Biopharma Fundamentals Correlations and Trends

By evaluating Integrated Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Integrated Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Integrated financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Integrated Biopharma OTC Stock history

Integrated Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Integrated is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Integrated Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Integrated Biopharma stock prices may prove useful in developing a viable investing in Integrated Biopharma
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people.

Integrated Biopharma OTC Stock Technical Analysis

Integrated Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Integrated Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Integrated Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Integrated Biopharma Period Price Range

Low
November 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Integrated Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQX Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Integrated Biopharma November 30, 2024 Market Strength

Market strength indicators help investors to evaluate how Integrated Biopharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integrated Biopharma shares will generate the highest return on investment. By undertsting and applying Integrated Biopharma otc stock market strength indicators, traders can identify Integrated Biopharma entry and exit signals to maximize returns

Integrated Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Integrated Biopharma's price direction in advance. Along with the technical and fundamental analysis of Integrated OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Integrated to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Integrated OTC Stock

If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios